Skip to main content

Advertisement

SpringerLink
Log in

Chronic lymphocytic leukaemia: When and how to treat

  • Leading Article
  • Published:
Blut Aims and scope Submit manuscript

Summary

In the 4th International Workshop on Chronic Lymphocytic Leukaemia (CLL), staging and response criteria were proposed to help physicians make decisions on when and how to treat patients with CLL. The most important factor is prolonging survival. There are several promising new treatment approaches under investigation, and the criteria proposed should facilitate future therapy trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bennett JM, Raphael B, Moore D, Silber R, Oken MM, Rubin P (1987) Comparison of chlorambucil and prednisone vs total body irradiation and chlorambucil/prednisone vs cytoxan, vincristine, prednisone for the therapy of active chronic lymphocytic leukemia: a long term follow-up of two ECOG studies. In: Gale RP, Rai KR (eds) Chronic Lymphocytic Leukemia: recent progress and future direction. UCLA Symposium on Molecular and Cellular Biology. New Series, vol 59. Alan Liss, New York, pp 317–327

    Google Scholar 

  2. Binet JL, Leporrier M, Dighiero G, Charron D, D`Athis Ph, Vaugier G, Merle Beral H, Natali JC, Raphael M, Nizet B, Follezou JY (1977) A clinical staging system for chronic lymphocytic leukemia. Cancer 40: 855–864

    Google Scholar 

  3. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier C, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Gremy F (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198–206

    Google Scholar 

  4. Binet JL, Dighiero G (editors) (1988) IVth International Workshop on Chronic Lymphocytic Leukemia. Nouv Rev Fr Hematol 30: 261–481

  5. Boussiotis VA, Pangalis GA (1988) Randomized trial with α2b interferon in 26 stage A untreated B-chronic lymphocytic leukemia patients. Nouv Rev Fr Hematol 30: 471–473

    Google Scholar 

  6. Catovsky D, Fooks J, Richards S (1988) The UK Medical Research Council CLL trials 1 and 2. Nouv Rev Fr Hematol 30: 423–427

    Google Scholar 

  7. Coonley CJ, Warrell RP, Itri LM, Lacher MJ (1983) Pilot study of 13-cis-retinoic acid in patients with advanced malignant lymphoma. Proc Am Soc Clin Oncol 2: C-865

  8. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia (1988) Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. N Engl J Med 319: 902–907

    Google Scholar 

  9. Ferrant A, Michaux JL, Sokal G (1986) Splenectomy in advanced chronic lymphocytic leukemia. Cancer 58: 2130–2135

    Google Scholar 

  10. Foon KA, Schroff RW, Bunn PA, Mayer D, Abrams PG, Fer M, Ochs J, Bottino GG, Sherwin SA, Carlo DJ, Herberman RB, Oldham RK (1984) Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia. Blood 64: 1085–1093

    Google Scholar 

  11. Foon KA, Bottino GC, Abrams PG, Fer MF, Longo DL, Schoenberger CS, Oldham RK (1985) Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia. Am J Med 78: 216–220

    Google Scholar 

  12. French Cooperative Group on Chronic Lymphocytic Leukaemia (1986) Effectiveness of “CHOP” regimen in advanced untreated chronic lymphocytic leukaemia. Lancet II: 1346–1349

    Google Scholar 

  13. French Cooperative Group on Chronic Lymphocytic Leukemia (1988). Comparison of the A, B, C staging and the Rai's staging from a large prospective series (935 patients). Nouv Rev Fr Hematol 30: 363–367

    Google Scholar 

  14. French Cooperative Group on Chronic Lymphocytic Leukemia (1988). Therapy of chronic lymphocytic leukemia: Results from the French cooperative trials. Nouv Rev Fr Hematol 30: 443–448

    Google Scholar 

  15. Gale RP, Binet JL, Catovsky D, Dighiero G, Montserrat E, Rai KR, Rozman C, Sawitsky A (1989) 4th International Workskop on CLL. Leukemia Res (in press)

  16. Gallhofer G, Melo JV, Spencer J, Catovsky D (1987) Splenectomy in advanced chronic lymphocytic leukaemia. Acta Haematol 77: 78–82

    Google Scholar 

  17. Galton DAG, Wiltshaw E, Szur L, Dacie JV (1961) The use of chlorambucil and steroid in the treatment of chronic lymphocytic leukaemia. Br J Haematol 7: 73–81

    Google Scholar 

  18. Grever MR, Leiby JM, Kraut EM, Wilson HE, Neidhardt JA, Wall RL, Balcerzak SP (1985) Low-dose deoxycoformycin in lymphoid malignancies. J Clin Oncol 3: 1196–1201

    Google Scholar 

  19. Grever MR, Kopecky KJ, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley R, Von Hoff DD, Balcerzak SP (1988) Fludarabine monophosphate: A potentially useful agent in chronic lymphocytic leukemia. Nouv Rev Fr Hematol 30: 457–459

    Google Scholar 

  20. Hansen MM, Andersen E, Christensen BR, Christiansen I, Geisler C, Kristensen D, Jensen KB, Junker P (1988) CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia (CLL): preliminary results of a randomized multicenter study. Nouv Rev Fr Hematol 30: 433–436

    Google Scholar 

  21. Hester JP, Gehan EA (1978) Cytoxan, adiamycin, prednisone (CAP) chemotherapy for chronic lymphocytic leukemia (CLL) (abstr). Abstracts AACR: 214c–853

  22. Huguley ChM Jr (1977) Treatment of chronic lymphocytic leukemia. Cancer Treat Rev 4: 261–273

    Google Scholar 

  23. Ideström K, Kimby E, Björkholm M, Mellstedt H, Engstedt L, Gahrton G, Johansson B, Killander D, Robérts K-H, Stalfelt A-M, Udén A-M, Wadman B, Wählby S (1982) Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone. Eur J Cancer Clin Oncol 18: 1117–1123

    Google Scholar 

  24. International Workshop on CLL (writing committee: Binet JL, Catovsky D, Chandra P, Dighiero G, Montserrat E, Rai KR, Sawitsky A (1981) Chronic lymphocytic leukaemia: Proposals for a revised prognostic staging system. Br J Haematol 48: 365–367

    Google Scholar 

  25. International Workshop on CLL (1989) Chronic lymphocytic leukemia: Recommendations for diagnosis, staging, and response criteria. Ann Intern Med 110: 236–238

    Google Scholar 

  26. Jacobs P, King HS (1987) A randomized prospective comparison of chemotherapy to total body irradiation as initial treatment for the indolent lymphoproliferative diseases. Blood 69: 1642–1646

    Google Scholar 

  27. Jaksic B, Brugatelli M (1988) High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL: ICIG Cll-01 trial. Nouv Rev Fr Hematol 30: 437–442

    Google Scholar 

  28. Johnson RE (1979) Treatment of chronic lymphocytic leukemia by total body irradiation alone and combined with chemotherapy. Int J Radiat Oncol Biol Phys 5: 159–164

    Google Scholar 

  29. Kay NE, Oken MM, Mazza JJ, Bradley EC (1988) Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2. Nouv Rev Fr Hematol 30: 475–478

    Google Scholar 

  30. Keating MJ, Kantarjian H, Talpaz M, Redman J, McCredie KB (1988) Fludarabine therapy in chronic lymphocytic leukemia (CLL). Nouv Rev Fr Hematol 30: 461–466

    Google Scholar 

  31. Keller JW, Johnson L, Raney M (1984) Phase II study of gallium nitrate (GaNO3) (NSC 152000) in refractory lymphoproliferative disorders. Proc ASCO 3: 247

    Google Scholar 

  32. Keller JW, Knospe WH, Raney M, Huguley ChM Jr, Johnson L, Bartolucci AA, Omura GA (1986) Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle-active consolidation chemotherapy. Cancer 58: 1185–1192

    Google Scholar 

  33. Kempin S, Lee III BJ, Thaler HT, Koziner B, Hecht S, Gee T, Arlin Z, Little C, Straus D, Reich L, Philipps E, AlMondhiry H, Dowling M, Mayer K, Clarkson B (1982) Combination chemotherapy of advanced chronic lymphocytic leukemia: The M-2 protocol vincristine, BCNU, cyclophosphamide, melphalan, and prednisolone). Blood 60: 1110–1121

    Google Scholar 

  34. Kempin S, Shank B (1987) Radiation in chronic lymphocytic leukemia. In: Gale RP, Rai KR (eds) Chronic lymphocytic leukemia: Recent progress and future direction. UCLA Symposium on Molecular and Cellular Biology. New Series, vol. 59. Alan R. Liss, New York, pp 337–352

    Google Scholar 

  35. Liepman M, Votaw ML (1978) The treatment of chronic lymphocytic leukemia with COP chemotherapy. Cancer 41: 1664–1669

    Google Scholar 

  36. Mantel N (1982) An uncontrolled clinical trial: treatment response or spontaneous improvement? Controlled Clin Trials 3: 369–370

    Google Scholar 

  37. Marti GE, Folks T, Longo DL, KLein H (1983) Therapeutic cytapheresis in chronic lymphocytic leukemia. J Clin Apheresis 1: 243–248

    Google Scholar 

  38. Michallet M, Corront B, Hollard D, Gratwohl A, Domingo A, Brunet S (1988) Allogenic bone marrow transplantation in chronic lymphocytic leukemia: Report from the European Cooperative Group for Bone Marrow Transplantation (8 cases). Nouv Rev Fr Hematol 30: 467–470

    Google Scholar 

  39. Montserrat E, Alcalá A, Parody R, Domingo A, García-Conde J, Bueno J, Ferrán C, Sanz MA, Giralt M, Rubio D, Antón I, Estapé J, Rozman C (1985) Treatment of chronic lymphocytic leukemia: A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone. Cancer 56: 2369–2375

    Google Scholar 

  40. Montserrat E, Viñolas N, Reverter JC, Rozman C (1988) Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early clinical stages. Nouv Rev Fr Hematol 30: 359–361

    Google Scholar 

  41. Montserrat E, Alcalá A, Alonso C, Besalduch J, Moraleda JM, García-Conde J, Gutierrez M, Gomis F, Garijo J, Guzmán MC, Estapé J, Rozman C (1988) A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C. Nouv Rev Fr Hematol 30: 429–432

    Google Scholar 

  42. O'Connell MJ, Colgan JP, Oken MM, Ritts RE, Hays NE, Itri LM (1986) Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia: An Eastern Cooperative Oncology Group pilot study. J Clin Oncol 4: 128–136

    Google Scholar 

  43. Oken M, Kaplan ME (1979) Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia. Cancer Treat Rep 63: 441–447

    Google Scholar 

  44. Piro LD, Carrera CJ, Beutler E, Carson DA (1988) 2-chlorodoxyadenosine: And effective new agent for the treatment of chronic lymphocytic leukemia. Blood 77: 1069–1073

    Google Scholar 

  45. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RW, Pasternak BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219–234

    Google Scholar 

  46. Rai KR, Montserrat E (1987) Prognostic factors in chronic lymphocytic leukemia. Semin Hematol 24: 252–256

    Google Scholar 

  47. Rai KR, Jagathambal K, Siegal FP, Grünwald H, Comas J, Mandelli F (1987) Cyclosporine in the treatment of refractory anemia and thrombocytopenia of chronic lymphocytic leukemia (abstr). Blood 70 [Suppl 1] 141 a

  48. Rozman C, Montserrat E, Rodriguez Fernández JM, Ayats R, Vallespi T, Parody R, Ríos A, Prados D, Morey M, Gomis F, Alcalá A, Gutierrez M, Maldonado J, González C, Giralt M, Hernández Nieto L, Cabrera A, Fernández Rañada JM, Brugués R (1984) La leucemia linfática crónica, acorta la vida? Sangre 29: 156–163

    Google Scholar 

  49. Rozman C, Monterrat E, Viñolas N, Urbano-Ispizua A, Ribera JM, Gallart T, Compernolle C (1988) Recombinant α2-Interferon in the treatment of B chronic lymphocytic leukemia in early stages. Blood 71: 1295–1298

    Google Scholar 

  50. Rozman C, Montserrat E (1988) Critical factors in new therapeutic approaches in chronic lymphocytic leukaemia. Nouv Rev Fr Hematol 30: 453–455

    Google Scholar 

  51. Rubin P, Bennett JM, Begg C, Bozdech MJ, Silber R (1981) The comparison of total body irradiation vs. chlorambucil and prednisone for remission induction of active chronic lymphocytic leukemia: An ECOG study. Part I: Total body irradiation: Response and toxicity. Int J Radiat Oncol Biol Phys 7: 1623–1627

    Google Scholar 

  52. Sawitsky A, Rai KR, Glidewell O, Silver RT (CALGB) (1977) Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood 50: 1049–1059

    Google Scholar 

  53. Scouros MA, Murphy S, Hester J (1980) Complete remission (CR) in chronic lymphocytic leukemia (CLL) with combination chemotherapy. Proc AACR and ASCO 21: 441 (abstr)

    Google Scholar 

  54. Scouros MA, Murphy SG (1982) Combination chemotherapy and staging in chronic lymphocytic leukemia. Proc AACR and ASCO C-449 (abstr)

  55. Shustik C, Mick R, Silver R, Sawitsky A, Rai KR, Shapiro L (CALGB) (1988) Treatment of early chronic lymphocytic leukemia: Intermittent chlorambucil versus observation. Hematol Oncol 6: 7–12

    Google Scholar 

  56. Tura S, Finelli C, Bandini G, Cavo M, Gobbi M (1988) Cyclosporin A in the treatment of CLL associated PRCA and bone marrow hypoplasia. Nouv Rev Fr Hematol 30: 479–481

    Google Scholar 

  57. Tura S (1988) Presented at the 4th International Workshop on CLL. Institut Pasteur, Paris, September 4–7, 1988

  58. Velasquez WS, McLaughlin P, Swan F, Kantarjian J, Cabanillas F, Barlogie B (1986) Dexamethasone, high dose ara-C, and cisplatin (DHAP). Combination for progressive chronic lymphocytic leukemia. Blood 68 [Suppl 11] 68: 234 (abstr)

    Google Scholar 

  59. Zagonel V, Tirelli U, Veronesi A, Galligioni E, Tumolo S, Roncadin M, Carone AA, Grigoleto E (1986) Teniposide is not effective in chronic lymphocytic leukemia. Blut 52: 59–61

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Postgraduate School of Haematology “Farreras Valenti”, Hospital Clinic, University of Barcelona, Villarroel 170, E-08036, Barcelona, Spain

    Ciril Rozman & Emilio Montserrat

Authors
  1. Ciril Rozman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emilio Montserrat
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported in part by grants 89-0353 (Fondo de Investigaciones Sanitarias de la Seguridad Social), PA 85-0234 and PB 86-0593 (Dirreción General de Investigación Científica y Técnica), Ministerio de Educación y Ciencia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rozman, C., Montserrat, E. Chronic lymphocytic leukaemia: When and how to treat. Blut 59, 467–474 (1989). https://doi.org/10.1007/BF00329491

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00329491

Key words

Search

Navigation